why choose us

First received: February 07, 2023

Clinical Trial: Supramarginal Resection in Glioblastoma Guided by Artificial Intelligence

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Glioblastoma

Study Type: INTERVENTIONAL


Official Title: Tailored Supramarginal Resection in Glioblastoma Guided by Artificial Intelligence-based Recurrence Probability Maps. A Non-randomized Pilot Study

Brief Summary: Glioblastomas are the most common and poorly prognostic primary brain neoplasms.Despite advances in surgical techniques and chemotherapy, the median survival time for these patients remains less than 15 months.This highlights the need for more effective treatments and improved prognostic tools.The globally accepted surgical strategy currently consists of achieving the maximum safe resection of the enhancing tumor volume.However, the non-enhancing peritumoral region contains viable cells that cause the inevitable…

Read more